Швајцарска - Италијански - Swissmedic (Swiss Agency for Therapeutic Products)

novartis pharma schweiz ag - omalizumabum - polvere e solvente per soluzione iniettabile - praeparatio cryodesiccata: omalizumabum 150 mg, histidini hydrochloridum monohydricum, histidinum, saccharum, polysorbatum 20, pro vitro. solvens: aqua ad iniectabile. - allergisches asthma, chronische spontane urtikaria, nasenpolypen - biotechnologika

Европска Унија - Италијански - EMA (European Medicines Agency)

samsung bioepis nl b.v. - eculizumab - emoglobinuria, parossistica - immunosoppressori - epysqli is indicated in adults and children for the treatment of paroxysmal nocturnal haemoglobinuria (pnh). evidence of clinical benefit is demonstrated in patients with haemolysis with clinical symptom(s) indicative of high disease activity, regardless of transfusion history.

Европска Унија - Италијански - EMA (European Medicines Agency)

roche registration gmbh - pertuzumab, trastuzumab - neoplasie al seno - agenti antineoplastici - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.

Швајцарска - Италијански - Swissmedic (Swiss Agency for Therapeutic Products)

iqone healthcare switzerland sa - trastuzumabum - polvere per soluzione per infusione - praeparatio cryodesiccata: trastuzumabum 440 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, pro vitro. solvant (i.v.): alcohol benzylicus 0.22 g, aqua ad iniectabile, q.s. ad solutionem pro 20 ml. - oncologique - biotechnologika

Швајцарска - Италијански - Swissmedic (Swiss Agency for Therapeutic Products)

iqone healthcare switzerland sa - trastuzumabum - polvere per soluzione per infusione - praeparatio cryodesiccata: trastuzumabum 150 mg, trehalosum dihydricum, histidini hydrochloridum monohydricum, histidinum, polysorbatum 20, pro vitro. - oncologique - biotechnologika

Европска Унија - Италијански - EMA (European Medicines Agency)

rotterdam biologics b.v. - bevacizumab - degenerazione maculare umida - oftalmologici - treatment of neovascular (wet) age-related macular degeneration (amd).

Швајцарска - Италијански - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - bevacizumabum - concentrato per soluzione per infusione - bevacizumabum 100 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 4 ml corresp. natrium 5.44 mg. - onkologikum - biotechnologika

Швајцарска - Италијански - Swissmedic (Swiss Agency for Therapeutic Products)

teva pharma ag - bevacizumabum - concentrato per soluzione per infusione - bevacizumabum 400 mg, trehalosum dihydricum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 16 ml corresp. natrium 21.76 mg. - onkologikum - biotechnologika

Италија - Италијански - Ministero della Salute

ceva salute animale s.p.a. - altrenogest - altrenogest - 4 millilitro (i), altrenogest - 4 ml, altrenogest - 4 mg/ml - altrenogest

Швајцарска - Италијански - Swissmedic (Swiss Agency for Therapeutic Products)

helvepharm ag - tramadoli hydrochloridum - tramadol zentiva; lösung zum einnehmen - tramadoli hydrochloridum 100 mg, e 202, ethanolum 96 per centum 161.8 mg, propylenglycolum 124.5 mg, saccharum 200 mg, polysorbatum 80, menthae piperitae aetheroleum, aqua purificata, ad solutionem pro 1 ml, corresp. 40 gutta, corresp. ethanolum 19 % v/v. - analgesico - synthetika